A-botulinic Toxin for Symptomatic Benign Prostate Hypertrophy
NCT01275521
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
127
Enrollment
OTHER
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
BONT-A intra-prostatic injection
DRUG:
Optimized medical BPH treatment
Sponsor
University Hospital, Bordeaux